Excess purine degradation in exercising muscles of patients with glycogen storage disease types V and VII.
Open Access
- 1 August 1985
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 76 (2), 556-560
- https://doi.org/10.1172/jci112006
Abstract
To investigate purine catabolism in exercising muscles of patients with muscle glycogen storage disease, we performed ischemic forearm exercise tests and quantitated metabolites appearing in cubital venous blood. Two patients with glycogen storage disease type V and three with glycogen storage disease type VII participated in this study. Basal lactate concentrations lowered in every patient with glycogen storage disease type V or type VII. Two patients with glycogen storage disease type VII, who had markedly elevated concentrations of serum uric acid (14.3 and 11.9 mg/dl, respectively), showed high basal concentrations of ammonia (118 and 79 mumol/liter, respectively; 23 +/- 4 mumol/liter in healthy controls) and of hypoxanthine (23.4 and 20.4 mumol/liter, respectively; 2.0 +/- 0.4 mumol/liter in healthy controls). Other patients showed near normal measurements of these metabolites. After forearm exercise, ammonia, inosine, and hypoxanthine levels increased greatly in every patient studied, in contrast with the lack of increase in lactate levels. The incremental area under the concentration curves for venous ammonia was 13-fold greater in the glycogen storage disease group than in controls (1,120 +/- 182 vs. 83 +/- 26 mumol X min/liter). The incremental areas of inosine and hypoxanthine were also greater in the glycogen storage disease group (29.2 +/- 7.2 vs. 0.4 +/- 0.1 and 134.6 +/- 23.1 vs. 14.9 +/- 3.2 mumol X min/liter, respectively). The incremental areas of ammonia in controls and in glycogen storage disease patients strongly correlated with those of hypoxanthine (r = 0.984, n = 11, P less than 0.005). These findings indicated that excess purine degradation occurred in the exercising muscles of patients with glycogen storage disease types V and VII, and suggested that the ATP pool in the exercising muscles may be deranged because of defective glycogenolysis or glycolysis.This publication has 32 references indexed in Scilit:
- Disruption of the purine nucleotide cycle by inhibition of adenylosuccinate lyase produces skeletal muscle dysfunction.Journal of Clinical Investigation, 1984
- A comparative study on glucagon effect between mcardle disease and tarui diseaseMuscle & Nerve, 1984
- Protons and AnaerobiosisScience, 1983
- High energy phosphate depletion in a model of defective muscle glycolysisMuscle & Nerve, 1983
- Phosphofructokinase (PFK) deficiency due to a catalytically inactive mutant M-type subunitAmerican Journal of Hematology, 1982
- Increased ammonia production during forearm ischemic work test in McArdle's diseaseKlinische Wochenschrift, 1981
- Possible correlation between binding of muscle type AMP deaminase to myofibrils and ammoniagenesis in rat skeletal muscle on electrical stimulationBiochemical and Biophysical Research Communications, 1981
- Examination of a Case of Suspected McArdle's Syndrome by31P Nuclear Magnetic ResonanceNew England Journal of Medicine, 1981
- On a possible role of IMP in the regulation of phosphorylase activity in skeletal muscleFEBS Letters, 1980
- Phosphofructokinase deficiency in skeletal muscle. A new type of glycogenosisBiochemical and Biophysical Research Communications, 1965